| Name | Sector |
Revenue
$mlns |
M&A Activity | Last 5 Years | ||
|---|---|---|---|---|---|---|
| Total | Buy | Sell | ||||
|
BioLife Solutions
NASDAQ : BLFS Bothell, Washington, United States website |
Life Science | 82 | 11 | 7 | 4 |
|
|
Juno Therapeutics, Inc.
Acquired Seattle, Washington, United States website |
Life Science | 18 | 4 | 4 | - |
|
|
Absolute Biotech
PE Backed Seattle, Washington, United States website |
Life Science | - | 3 | 3 | - |
|
|
Immunome
NASDAQ : IMNM Bothell, Washington, United States website |
Life Science | 9 | 3 | 3 | - |
|
|
Absci
NASDAQ : ABSI Vancouver, Washington, United States website |
Life Science | 4 | 2 | 2 | - |
|
|
Adhera Therapeutics, Inc.
Private Bothell, Washington, United States website |
Life Science | 1 | 2 | 2 | - |
|
|
Alpine Immune Sciences
Acquired Seattle, Washington, United States website |
Life Science | 59 | 1 | 1 | - |
|
|
Adaptive Biotechnologies Corp.
Private Seattle, Washington, United States website |
Life Science | - | 1 | 1 | - |
|
|
CTI BioPharma
Acquired Seattle, Washington, United States website |
Life Science | 54 | 2 | 1 | 1 |
|
|
Sana Biotechnology
NASDAQ : SANA Seattle, Washington, United States website |
Life Science | - | 1 | 1 | - |
|
|
Chinook Therapeutics
Acquired Seattle, Washington, United States website |
Life Science | - | 1 | 1 | - |
|
|
Omeros
NASDAQ : OMER Seattle, Washington, United States website |
Life Science | 169 | 2 | 1 | 1 |
|
|
Eliem Therapeutics
Private Redmond, Washington, United States website |
Life Science | - | 1 | 1 | - |
|
|
Seagen
Acquired Bothell, Washington, United States website |
Life Science | 1,962 | 1 | 1 | - |
|
|
Modulus Therapeutics - Cell Therapy Assets
Acquired Seattle, Washington, United States |
Life Science | - | - | - | - |
|
|
Alvaxa Biosciences
Acquired Seattle, Washington, United States |
Life Science | - | - | - | - |
|
Mergr was built to make it easy to understand who owns which companies — and how they got there.
Whether you're researching private equity-backed businesses, recent acquisitions, or potential targets, Mergr provides structured access to thousands of companies, investors, and ownership histories.
The platform is powerful but easy to use — so you can quickly surface relevant companies and move from research to action.
Full access to Mergr's investor, acquirer, and transaction data starts here.